Emerging therapies in the management of high-risk non-muscle invasive bladder cancer (HRNMIBC)
ConclusionDespite limited intravesical treatment options in BCG failure patients, there are several promising therapies currently being developed and several with promising early results.
Source: World Journal of Urology - Category: Urology & Nephrology Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Cancer Vaccines | Clinical Trials | Gene Therapy | Genetics | Immunotherapy | Study | Urology & Nephrology | Vaccines